Eye implant to dispense ganciclovir data

Results of a Phase II trial of the implant from CHIR's Chiron Vision Corp. unit (Irvine, Calif.) showed elimination of signs of active infection for a median of 226 days, about eight

Read the full 320 word article

How to gain access

Continue reading with a
two-week free trial.